BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

77 related articles for article (PubMed ID: 10366566)

  • 41. Piecing together more efficient gene expression.
    Somia NV; Kafri T; Verma IM
    Nat Biotechnol; 1999 Mar; 17(3):224-5. PubMed ID: 10096283
    [No Abstract]   [Full Text] [Related]  

  • 42. Two novel adenovirus vector systems permitting regulated protein expression in gene transfer experiments.
    Molin M; Shoshan MC; Ohman-Forslund K; Linder S; Akusjärvi G
    J Virol; 1998 Oct; 72(10):8358-61. PubMed ID: 9733884
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Differentiation of the immortalized adult neuronal progenitor cell line HC2S2 into neurons by regulatable suppression of the v-myc oncogene.
    Hoshimaru M; Ray J; Sah DW; Gage FH
    Proc Natl Acad Sci U S A; 1996 Feb; 93(4):1518-23. PubMed ID: 8643664
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Construction and characterization of a one-plasmid system for the controlled expression of genes in mammalian cells by tetracycline.
    O'Brien K; Otto K; Rao RN
    Gene; 1997 Jan; 184(1):115-20. PubMed ID: 9016960
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Co-regulation of two gene activities by tetracycline via a bidirectional promoter.
    Baron U; Freundlieb S; Gossen M; Bujard H
    Nucleic Acids Res; 1995 Sep; 23(17):3605-6. PubMed ID: 7567477
    [No Abstract]   [Full Text] [Related]  

  • 46. Efficient and inducible production of human interleukin 6 in Chinese hamster ovary cells using a novel expression system.
    Zhang Y; Katakura Y; Ohashi H; Shirahata S
    Cytotechnology; 1997 Nov; 25(1-3):53-60. PubMed ID: 22358879
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Tetracycline regulated expression of vimentin in fibroblasts derived from vimentin null mice.
    Holwell TA; Schweitzer SC; Evans RM
    J Cell Sci; 1997 Aug; 110 ( Pt 16)():1947-56. PubMed ID: 9296393
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Treatment by methyl methanesulfonate induces up-regulation of cytomegalovirus immediate/early promoter.
    Nabirochkina EN; Ivanov AV
    Biotechniques; 2000 Oct; 29(4):732-4, 736. PubMed ID: 11056800
    [No Abstract]   [Full Text] [Related]  

  • 49. Tetracycline-regulatable system to tightly control gene expression in the pathogenic fungus Candida albicans.
    Nakayama H; Mio T; Nagahashi S; Kokado M; Arisawa M; Aoki Y
    Infect Immun; 2000 Dec; 68(12):6712-9. PubMed ID: 11083786
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Efficacy of tetracycline-controlled gene expression is influenced by cell type.
    Ackland-Berglund CE; Leib DA
    Biotechniques; 1995 Feb; 18(2):196-200. PubMed ID: 7727112
    [No Abstract]   [Full Text] [Related]  

  • 51. Intrinsic hypoxia sensitivity of the cytomegalovirus promoter.
    Wendland K; Thielke M; Meisel A; Mergenthaler P
    Cell Death Dis; 2015 Oct; 6(10):e1905. PubMed ID: 26469954
    [No Abstract]   [Full Text] [Related]  

  • 52. Animal models in cardiovascular diseases: new insights from conditional models.
    Nguyen Din Cat A; Sainte-Marie Y; Jaisser F
    Handb Exp Pharmacol; 2007; (178):377-405. PubMed ID: 17203664
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Resistance to murine cytomegalovirus infection: H-2-linked genetic regulation of an immunopathological condition?
    Shearer GM
    Immunol Today; 1981 Apr; 2(4):60-1. PubMed ID: 25291341
    [No Abstract]   [Full Text] [Related]  

  • 54. Antiviral activities of four marine sulfated glycans against adenovirus and human cytomegalovirus.
    Zoepfl M; Dwivedi R; Taylor MC; Pomin VH; McVoy MA
    Antiviral Res; 2021 Jun; 190():105077. PubMed ID: 33864843
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Anti-cytomegalovirus activity of the anthraquinone atanyl blue PRL.
    Alam Z; Al-Mahdi Z; Zhu Y; McKee Z; Parris DS; Parikh HI; Kellogg GE; Kuchta A; McVoy MA
    Antiviral Res; 2015 Feb; 114():86-95. PubMed ID: 25499125
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Perivascular stromal cells as a potential reservoir of human cytomegalovirus.
    Soland MA; Keyes LR; Bayne R; Moon J; Porada CD; St Jeor S; Almeida-Porada G
    Am J Transplant; 2014 Apr; 14(4):820-30. PubMed ID: 24592822
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Analysis of essential viral gene functions after highly efficient adenofection of cells with cloned human cytomegalovirus genomes.
    Elbasani E; Gabaev I; Steinbrück L; Messerle M; Borst EM
    Viruses; 2014 Jan; 6(1):354-70. PubMed ID: 24452007
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Ribonucleotide reductase inhibitors hydroxyurea, didox, and trimidox inhibit human cytomegalovirus replication in vitro and synergize with ganciclovir.
    Bhave S; Elford H; McVoy MA
    Antiviral Res; 2013 Oct; 100(1):151-8. PubMed ID: 23933116
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Conditional cytomegalovirus replication in vitro and in vivo.
    Rupp B; Ruzsics Z; Sacher T; Koszinowski UH
    J Virol; 2005 Jan; 79(1):486-94. PubMed ID: 15596841
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Cloning of the human cytomegalovirus (HCMV) genome as an infectious bacterial artificial chromosome in Escherichia coli: a new approach for construction of HCMV mutants.
    Borst EM; Hahn G; Koszinowski UH; Messerle M
    J Virol; 1999 Oct; 73(10):8320-9. PubMed ID: 10482582
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.